Vanderbilt University grants Cumberland exclusive, worldwide rights to develop and commercialize Hepatoren to treat hepatorenal syndrome (HRS)

Vanderbilt University

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cumberland Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$105.5m on 04/22/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced